ArticlePloS one2020
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.
Holger H H Erb et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticlePloS one2020
Holger H H Erb et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.